Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.

Completed · Phase 1/Phase 2

Conditions studied: Breast Cancer

In brief

To determine the effects of endurance exercise training on cardiopulmonary fitness in breast cancer patients undergoing neoadjuvant chemotherapy.

Key facts

Study ID

NCT00405678

Run by

Duke University

People needed

23

Starts

2006-09-01

Expected to finish

2010-09-01

Last updated by the study team

2014-07-11

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Histologically confirmed operable primary breast cancer
• Age 18 or older
• Karnofsky performance status greater than 70
• No previous malignancy
• Absence of significant cardiac disease (left ventricular ejection fraction greater than or equal to 50%)
• No hormonal replacement therapy use within the past month
• Not pregnant
• Ability to read and understand English
• Signed written informed consent prior to beginning protocol specific procedures
• Willing to travel to DUMC to exercise three times per week
• Primary treating oncologist approval

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.